Extended duration of the detectable stage by adding HPV test in cervical cancer screening

Marie, M E van den Akker-van; Ballegooijen, M van; Rozendaal, L.; Meijer, C. J. L. M.; Habbema, J. D. F.

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

Files

89-6601355a.pdf (83.46 KB)

Authors

Marie, M E van den Akker-van

Ballegooijen, M van

Rozendaal, L.

Meijer, C. J. L. M.

Habbema, J. D. F.

Issue Date

2003-11-11

Type

Article

Language

en_US

Keywords

Human Papillomavirus , Cervical Cancer Screening Model

Abstract

The human papillomavirus test (HPV) test could improve the (cost−) effectiveness of cervical screening by selecting women with a very low risk for cervical cancer during a long period. An analysis of a longitudinal study suggests that women with a negative Pap smear and a negative HPV test have a strongly reduced risk of developing cervical abnormalities in the years following the test, and that HPV testing lengthens the detectable stage by 2–5 years, compared to Pap smear detection alone.

Citation

van den Akker-van Marie, M. E., van Ballegooijen, M., Rozendaal, L., Meijer, C. J., & Habbema, J. D. (2003). Extended duration of the detectable stage by adding HPV test in cervical cancer screening. British journal of cancer, 89(10), 1830–1833. https://doi.org/10.1038/sj.bjc.6601355

Publisher

British Journal of Cancer